DETERMINANTS AND CONSEQUENCES OF DRUG EXCRETION IN BREAST-MILK

被引：56

作者：

WILSON, JT ^{[1
]}

机构：

[1] LOUISIANA STATE UNIV, MED CTR, DEPT PEDIAT, SHREVEPORT, LA 71130 USA

来源：

DRUG METABOLISM REVIEWS | 1983年 / 14卷 / 04期

关键词：

D O I：

10.3109/03602538308991402

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：619 / 652

页数：34

共 86 条

[1]

[Anonymous], 1981, PEDIATRICS, V68, P435

[2] PHARMACOKINETIC ASPECTS OF THEOPHYLLINE IN PREMATURE NEWBORNS [J].

ARANDA, JV ;

SITAR, DS ;

PARSONS, WD ;

LOUGHNAN, PM ;

NEIMS, AH .

NEW ENGLAND JOURNAL OF MEDICINE, 1976, 295 (08) :413-416

[3]

BALDWIN R, 1974, LACTATION

[4]

BERLIN CM, 1980, PEDIATR PHARMACOL, V1, P135

[5]

BERLIN CM, 1980, DRUG CHEM RISKS FETU

[6] EXCRETION OF PARACETAMOL IN HUMAN-BREAST MILK [J].

BITZEN, PO ;

GUSTAFSSON, B ;

JOSTELL, KG ;

MELANDER, A ;

WAHLINBOLL, E .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 20 (02) :123-125

[7]

BOBOK I, 1974, ACTA PAEDIATR HUNG, V15, P95

[8]

BOWES W A JR, 1980, Clinical Obstetrics and Gynecology, V23, P1073, DOI 10.1097/00003081-198012000-00010

[9]

BROWN RD, 1981, DRUGS BREAST MILK

[10]

BUCHANAN RA, 1969, PEDIATRICS, V43, P114

← 1 2 3 4 5 6 7 8 9 →